Switch to:
Also traded in: Germany, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.49
SYK's Cash-to-Debt is ranked lower than
72% of the 269 Companies
in the Global Medical Devices industry.

( Industry Median: 1.84 vs. SYK: 0.49 )
Ranked among companies with meaningful Cash-to-Debt only.
SYK' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.05  Med: 1.96 Max: 164.16
Current: 0.49
0.05
164.16
Equity-to-Asset 0.47
SYK's Equity-to-Asset is ranked lower than
69% of the 254 Companies
in the Global Medical Devices industry.

( Industry Median: 0.62 vs. SYK: 0.47 )
Ranked among companies with meaningful Equity-to-Asset only.
SYK' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.23  Med: 0.63 Max: 0.73
Current: 0.47
0.23
0.73
Interest Coverage N/A
SYK's Interest Coverage is ranked higher than
73% of the 228 Companies
in the Global Medical Devices industry.

( Industry Median: 83.04 vs. SYK: N/A )
Ranked among companies with meaningful Interest Coverage only.
SYK' s Interest Coverage Range Over the Past 10 Years
Min: 24.66  Med: N/A Max: No Debt
Current: N/A
Piotroski F-Score: 7
Altman Z-Score: 4.40
Beneish M-Score: -2.26
WACC vs ROIC
6.11%
16.42%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 19.13
SYK's Operating Margin % is ranked higher than
88% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. SYK: 19.13 )
Ranked among companies with meaningful Operating Margin % only.
SYK' s Operating Margin % Range Over the Past 10 Years
Min: 12.88  Med: 20.21 Max: 23.92
Current: 19.13
12.88
23.92
Net Margin % 14.54
SYK's Net Margin % is ranked higher than
84% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 2.51 vs. SYK: 14.54 )
Ranked among companies with meaningful Net Margin % only.
SYK' s Net Margin % Range Over the Past 10 Years
Min: 5.32  Med: 15.59 Max: 17.39
Current: 14.54
5.32
17.39
ROE % 18.18
SYK's ROE % is ranked higher than
86% of the 249 Companies
in the Global Medical Devices industry.

( Industry Median: 3.48 vs. SYK: 18.18 )
Ranked among companies with meaningful ROE % only.
SYK' s ROE % Range Over the Past 10 Years
Min: 5.84  Med: 18.18 Max: 21.28
Current: 18.18
5.84
21.28
ROA % 8.49
SYK's ROA % is ranked higher than
80% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 0.81 vs. SYK: 8.49 )
Ranked among companies with meaningful ROA % only.
SYK' s ROA % Range Over the Past 10 Years
Min: 3.12  Med: 10.96 Max: 15.38
Current: 8.49
3.12
15.38
ROC (Joel Greenblatt) % 77.36
SYK's ROC (Joel Greenblatt) % is ranked higher than
91% of the 267 Companies
in the Global Medical Devices industry.

( Industry Median: 7.00 vs. SYK: 77.36 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
SYK' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 43.65  Med: 67.67 Max: 108.61
Current: 77.36
43.65
108.61
3-Year Revenue Growth Rate 8.20
SYK's 3-Year Revenue Growth Rate is ranked higher than
66% of the 228 Companies
in the Global Medical Devices industry.

( Industry Median: 4.60 vs. SYK: 8.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
SYK' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 4.9  Med: 10.4 Max: 32.5
Current: 8.2
4.9
32.5
3-Year EBITDA Growth Rate 20.50
SYK's 3-Year EBITDA Growth Rate is ranked higher than
74% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 4.50 vs. SYK: 20.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
SYK' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -9.6  Med: 13.7 Max: 59.8
Current: 20.5
-9.6
59.8
3-Year EPS without NRI Growth Rate 18.30
SYK's 3-Year EPS without NRI Growth Rate is ranked higher than
71% of the 194 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. SYK: 18.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
SYK' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -27  Med: 18.3 Max: 153
Current: 18.3
-27
153
GuruFocus has detected 6 Warning Signs with Stryker Corp $SYK.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» SYK's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

SYK Guru Trades in Q1 2016

Murray Stahl 2,000 sh (New)
Joel Greenblatt 85,828 sh (New)
George Soros 20,300 sh (New)
Pioneer Investments 37,559 sh (+39.46%)
Vanguard Health Care Fund 2,498,900 sh (unchged)
PRIMECAP Management 295,500 sh (unchged)
Ray Dalio Sold Out
Jim Simons Sold Out
Steven Cohen Sold Out
Diamond Hill Capital 917,488 sh (-2.08%)
Donald Yacktman 1,948,574 sh (-5.46%)
Yacktman Fund 1,600,000 sh (-5.88%)
Jeremy Grantham 1,287,095 sh (-12.29%)
Robert Olstein 45,000 sh (-13.46%)
Paul Tudor Jones 4,200 sh (-97.98%)
» More
Q2 2016

SYK Guru Trades in Q2 2016

Pioneer Investments 43,865 sh (+16.79%)
Jeremy Grantham 1,321,268 sh (+2.66%)
Vanguard Health Care Fund 2,498,900 sh (unchged)
PRIMECAP Management 295,500 sh (unchged)
Murray Stahl 2,000 sh (unchged)
George Soros Sold Out
Diamond Hill Capital 883,282 sh (-3.73%)
Paul Tudor Jones 3,700 sh (-11.90%)
Robert Olstein 38,000 sh (-15.56%)
Joel Greenblatt 63,965 sh (-25.47%)
Donald Yacktman 1,402,704 sh (-28.01%)
Yacktman Fund 1,100,000 sh (-31.25%)
» More
Q3 2016

SYK Guru Trades in Q3 2016

Louis Moore Bacon 4,820 sh (New)
Jeremy Grantham 1,385,768 sh (+4.88%)
Murray Stahl 2,000 sh (unchged)
Joel Greenblatt Sold Out
Pioneer Investments 42,064 sh (-4.11%)
Diamond Hill Capital 843,629 sh (-4.49%)
Yacktman Fund 1,000,000 sh (-9.09%)
Donald Yacktman 1,264,330 sh (-9.86%)
Paul Tudor Jones 3,200 sh (-13.51%)
Vanguard Health Care Fund 2,159,500 sh (-13.58%)
Robert Olstein 32,000 sh (-15.79%)
PRIMECAP Management 228,400 sh (-22.71%)
» More
Q4 2016

SYK Guru Trades in Q4 2016

Steven Cohen 337,600 sh (New)
Pioneer Investments 45,949 sh (+9.24%)
Diamond Hill Capital 919,621 sh (+9.01%)
Jeremy Grantham 1,470,782 sh (+6.13%)
PRIMECAP Management 228,400 sh (unchged)
Murray Stahl 2,000 sh (unchged)
Paul Tudor Jones Sold Out
Donald Yacktman 1,140,765 sh (-9.77%)
Yacktman Fund 900,000 sh (-10.00%)
Robert Olstein 28,500 sh (-10.94%)
Vanguard Health Care Fund 1,654,500 sh (-23.39%)
» More
» Details

Insider Trades

Latest Guru Trades with SYK

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339112    SIC: 3841
Compare:NYSE:BSX, NAS:ISRG, NYSE:ZBH, NYSE:STJ, NYSE:EW, NYSE:ABT, OTCPK:SNNUF, NYSE:TFX, OTCPK:SONVY, NAS:ALGN, NYSE:VAR, OTCPK:CNVVY, OTCPK:CHEOY, OTCPK:WILYY, NAS:ABMD, NAS:MASI, NAS:NUVA, OTCPK:FSPKF, OTCPK:EKTAF, NAS:IART » details
Traded in other countries:SYK.Germany, SYK.Switzerland, 0R2S.UK,
Stryker Corporation is a medical technology company. The Company offers medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products.

Stryker Corp was incorporated in Michigan in 1946. It is a medical technology company. The Company offers medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products. Its business segments are Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics products consist of implants used in hip and knee joint replacements and trauma and extremities surgeries. The Company supports surgeons with the technology and services needed as the company develops new surgical techniques. The MedSurg products include surgical equipment and surgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical); and reprocessed and remanufactured medical devices (Sustainability) as well as other medical device products used in a variety of medical specialties. The Neurotechnology and Spine products include both neurosurgical and neurovascular devices. Its neurotechnology offering includes products used for minimally invasive endovascular techniques; a comprehensive line of products for traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also develops, manufacture and market spinal implant products including cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. The Company's competitors include Zimmer Biomet Holdings, Inc. (Zimmer), DePuy Synthes (companies of Johnson & Johnson) and Smith & Nephew plc (Smith & Nephew). The Company's businesses are subject to varying degrees of governmental regulation in the countries in which the company operates and the general trend is toward increasingly stringent regulation.

Top Ranked Articles about Stryker Corp

Answers to the Hardest Question: When Do I Sell a Stock? There are 2 primary reasons it makes sense to sell a stock
The most common complaint I have heard from investors over my 40-plus years in the financial services industry is as follows: "Everyone wants to tell me what to buy and when, but no one ever tells me when to sell." Read more...

Ratios

vs
industry
vs
history
PE Ratio 29.56
SYK's PE Ratio is ranked lower than
54% of the 157 Companies
in the Global Medical Devices industry.

( Industry Median: 27.24 vs. SYK: 29.56 )
Ranked among companies with meaningful PE Ratio only.
SYK' s PE Ratio Range Over the Past 10 Years
Min: 11.3  Med: 24.99 Max: 71.37
Current: 29.56
11.3
71.37
Forward PE Ratio 20.16
SYK's Forward PE Ratio is ranked higher than
69% of the 55 Companies
in the Global Medical Devices industry.

( Industry Median: 24.10 vs. SYK: 20.16 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 29.56
SYK's PE Ratio without NRI is ranked lower than
54% of the 157 Companies
in the Global Medical Devices industry.

( Industry Median: 28.18 vs. SYK: 29.56 )
Ranked among companies with meaningful PE Ratio without NRI only.
SYK' s PE Ratio without NRI Range Over the Past 10 Years
Min: 11.3  Med: 25.21 Max: 71.37
Current: 29.56
11.3
71.37
Price-to-Owner-Earnings 35.47
SYK's Price-to-Owner-Earnings is ranked lower than
55% of the 110 Companies
in the Global Medical Devices industry.

( Industry Median: 32.45 vs. SYK: 35.47 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
SYK' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 12.61  Med: 25.99 Max: 281.54
Current: 35.47
12.61
281.54
PB Ratio 5.05
SYK's PB Ratio is ranked lower than
70% of the 250 Companies
in the Global Medical Devices industry.

( Industry Median: 3.09 vs. SYK: 5.05 )
Ranked among companies with meaningful PB Ratio only.
SYK' s PB Ratio Range Over the Past 10 Years
Min: 2.19  Med: 3.43 Max: 6.24
Current: 5.05
2.19
6.24
PS Ratio 4.32
SYK's PS Ratio is ranked lower than
65% of the 252 Companies
in the Global Medical Devices industry.

( Industry Median: 3.24 vs. SYK: 4.32 )
Ranked among companies with meaningful PS Ratio only.
SYK' s PS Ratio Range Over the Past 10 Years
Min: 1.94  Med: 3.35 Max: 5.29
Current: 4.32
1.94
5.29
Price-to-Free-Cash-Flow 36.84
SYK's Price-to-Free-Cash-Flow is ranked lower than
63% of the 102 Companies
in the Global Medical Devices industry.

( Industry Median: 29.41 vs. SYK: 36.84 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
SYK' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 11.77  Med: 19.91 Max: 111.1
Current: 36.84
11.77
111.1
Price-to-Operating-Cash-Flow 26.84
SYK's Price-to-Operating-Cash-Flow is ranked lower than
64% of the 129 Companies
in the Global Medical Devices industry.

( Industry Median: 20.17 vs. SYK: 26.84 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
SYK' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.32  Med: 17.09 Max: 58.83
Current: 26.84
10.32
58.83
EV-to-EBIT 23.77
SYK's EV-to-EBIT is ranked lower than
55% of the 137 Companies
in the Global Medical Devices industry.

( Industry Median: 21.56 vs. SYK: 23.77 )
Ranked among companies with meaningful EV-to-EBIT only.
SYK' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.8  Med: 14.95 Max: 35.3
Current: 23.77
6.8
35.3
EV-to-EBITDA 18.98
SYK's EV-to-EBITDA is ranked lower than
60% of the 142 Companies
in the Global Medical Devices industry.

( Industry Median: 16.07 vs. SYK: 18.98 )
Ranked among companies with meaningful EV-to-EBITDA only.
SYK' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.5  Med: 12.3 Max: 25.6
Current: 18.98
5.5
25.6
PEG Ratio 4.71
SYK's PEG Ratio is ranked lower than
71% of the 78 Companies
in the Global Medical Devices industry.

( Industry Median: 2.42 vs. SYK: 4.71 )
Ranked among companies with meaningful PEG Ratio only.
SYK' s PEG Ratio Range Over the Past 10 Years
Min: 0.63  Med: 2.21 Max: 19.08
Current: 4.71
0.63
19.08
Shiller PE Ratio 40.01
SYK's Shiller PE Ratio is ranked higher than
64% of the 50 Companies
in the Global Medical Devices industry.

( Industry Median: 49.99 vs. SYK: 40.01 )
Ranked among companies with meaningful Shiller PE Ratio only.
SYK' s Shiller PE Ratio Range Over the Past 10 Years
Min: 20.27  Med: 30.07 Max: 71.13
Current: 40.01
20.27
71.13
Current Ratio 2.50
SYK's Current Ratio is ranked higher than
56% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 2.24 vs. SYK: 2.50 )
Ranked among companies with meaningful Current Ratio only.
SYK' s Current Ratio Range Over the Past 10 Years
Min: 1.61  Med: 2.37 Max: 4.76
Current: 2.5
1.61
4.76
Quick Ratio 1.85
SYK's Quick Ratio is ranked higher than
56% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 1.64 vs. SYK: 1.85 )
Ranked among companies with meaningful Quick Ratio only.
SYK' s Quick Ratio Range Over the Past 10 Years
Min: 0.98  Med: 1.85 Max: 4.1
Current: 1.85
0.98
4.1
Days Inventory 181.41
SYK's Days Inventory is ranked lower than
71% of the 246 Companies
in the Global Medical Devices industry.

( Industry Median: 125.61 vs. SYK: 181.41 )
Ranked among companies with meaningful Days Inventory only.
SYK' s Days Inventory Range Over the Past 10 Years
Min: 144.2  Med: 161.51 Max: 181.41
Current: 181.41
144.2
181.41
Days Sales Outstanding 63.40
SYK's Days Sales Outstanding is ranked higher than
56% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 66.89 vs. SYK: 63.40 )
Ranked among companies with meaningful Days Sales Outstanding only.
SYK' s Days Sales Outstanding Range Over the Past 10 Years
Min: 59.31  Med: 61.84 Max: 63.4
Current: 63.4
59.31
63.4
Days Payable 41.65
SYK's Days Payable is ranked lower than
66% of the 221 Companies
in the Global Medical Devices industry.

( Industry Median: 58.05 vs. SYK: 41.65 )
Ranked among companies with meaningful Days Payable only.
SYK' s Days Payable Range Over the Past 10 Years
Min: 33.46  Med: 43.2 Max: 51.96
Current: 41.65
33.46
51.96

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.20
SYK's Dividend Yield % is ranked lower than
66% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.74 vs. SYK: 1.20 )
Ranked among companies with meaningful Dividend Yield % only.
SYK' s Dividend Yield % Range Over the Past 10 Years
Min: 0.21  Med: 1.27 Max: 1.66
Current: 1.2
0.21
1.66
Dividend Payout Ratio 0.36
SYK's Dividend Payout Ratio is ranked higher than
71% of the 115 Companies
in the Global Medical Devices industry.

( Industry Median: 0.42 vs. SYK: 0.36 )
Ranked among companies with meaningful Dividend Payout Ratio only.
SYK' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.05  Med: 0.24 Max: 0.94
Current: 0.36
0.05
0.94
3-Year Dividend Growth Rate 12.50
SYK's 3-Year Dividend Growth Rate is ranked higher than
58% of the 78 Companies
in the Global Medical Devices industry.

( Industry Median: 8.40 vs. SYK: 12.50 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
SYK' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -12  Med: 21.6 Max: 81.9
Current: 12.5
-12
81.9
Forward Dividend Yield % 1.32
SYK's Forward Dividend Yield % is ranked lower than
67% of the 181 Companies
in the Global Medical Devices industry.

( Industry Median: 1.81 vs. SYK: 1.32 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 2.50
SYK's 5-Year Yield-on-Cost % is ranked higher than
66% of the 225 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. SYK: 2.50 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
SYK' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.44  Med: 2.64 Max: 3.46
Current: 2.5
0.44
3.46
3-Year Average Share Buyback Ratio 0.30
SYK's 3-Year Average Share Buyback Ratio is ranked higher than
85% of the 203 Companies
in the Global Medical Devices industry.

( Industry Median: -3.40 vs. SYK: 0.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SYK' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -0.8  Med: 0.1 Max: 1.9
Current: 0.3
-0.8
1.9

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 2.18
SYK's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
50% of the 126 Companies
in the Global Medical Devices industry.

( Industry Median: 2.19 vs. SYK: 2.18 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
SYK' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1  Med: 1.79 Max: 99.06
Current: 2.18
1
99.06
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.76
SYK's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
73% of the 22 Companies
in the Global Medical Devices industry.

( Industry Median: 2.39 vs. SYK: 2.76 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.28
SYK's Price-to-Median-PS-Value is ranked lower than
64% of the 211 Companies
in the Global Medical Devices industry.

( Industry Median: 1.06 vs. SYK: 1.28 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
SYK' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.7  Med: 1.15 Max: 1.53
Current: 1.28
0.7
1.53
Price-to-Peter-Lynch-Fair-Value 4.89
SYK's Price-to-Peter-Lynch-Fair-Value is ranked lower than
84% of the 57 Companies
in the Global Medical Devices industry.

( Industry Median: 1.62 vs. SYK: 4.89 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
SYK' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.63  Med: 1.77 Max: 51.21
Current: 4.89
0.63
51.21
Earnings Yield (Greenblatt) % 4.21
SYK's Earnings Yield (Greenblatt) % is ranked higher than
70% of the 242 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. SYK: 4.21 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
SYK' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.8  Med: 6.7 Max: 14.6
Current: 4.21
2.8
14.6
Forward Rate of Return (Yacktman) % 8.82
SYK's Forward Rate of Return (Yacktman) % is ranked lower than
51% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 8.96 vs. SYK: 8.82 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
SYK' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -5.9  Med: 8 Max: 25.3
Current: 8.82
-5.9
25.3

More Statistics

Revenue (TTM) (Mil) $11,325
EPS (TTM) $ 4.35
Beta0.59
Short Percentage of Float2.34%
52-Week Range $98.00 - 129.66
Shares Outstanding (Mil)372.88

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 12,145 12,907 13,655
EPS ($) 6.35 7.02 7.88
EPS without NRI ($) 6.35 7.02 7.88
EPS Growth Rate
(Future 3Y To 5Y Estimate)
8.43%
Dividends per Share ($) 1.56 1.89 2.09
» More Articles for SYK

Headlines

Articles On GuruFocus.com
6 Stocks That Beat the Market Oct 05 2016 
Healthcare Winners: Stryker Corp., UnitedHealth Group Inc. Aug 29 2016 
Johnson & Johnson Reports 4% Sales Growth for the Second Quarter Jul 22 2016 
Becton Dickinson: 19% EPS Growth With Good Dividends Jun 26 2016 
Answers to the Hardest Question: When Do I Sell a Stock? Jun 23 2016 
Weekly Insider Sells: Medivation, JPMorgan Chase, Stryker, Sabre Jan 26 2016 
Stryker: An Expensive Growth Play Dec 26 2015 
Louis Moore Bacon's Largest 3rd Quarter Trades Dec 23 2015 
Eric Mindich Sells Stakes in Catamaran and Alphabet in 3rd Quarter Dec 02 2015 
Weekly Insider Sells Highlights: Nike, Intuitive Surgical, Travelers Companies, Stryker Oct 26 2015 

More From Other Websites
Stryker Corp. : SYK-US: Dividend Analysis : December 30th, 2016 (record date) : By the numbers :... Feb 24 2017
Why Is Stryker Corp (SYK) Up 5% Since the Last Earnings Report? Feb 24 2017
Stryker to participate in Cowen & Company 37th Annual Health Care Conference Feb 21 2017
STRYKER CORP Financials Feb 15 2017
STRYKER CORP Files SEC form 10-K, Annual Report Feb 09 2017
Smith & Nephew hurt by tough markets in China and Gulf states Feb 09 2017
Smith & Nephew hurt by tough markets in China and Gulf states Feb 09 2017
Stryker declares a $0.425 per share quarterly dividend Feb 08 2017
Post Earnings Coverage as Stryker's Revenue Gained 16.7% on Constant Currency Basis; Adjusted EPS... Feb 07 2017
Stryker Orthopaedics Corp wins $486 mln Pentagon contract -statement Feb 06 2017
ETFs with exposure to Stryker Corp. : February 2, 2017 Feb 02 2017
Stryker Corp. :SYK-US: Earnings Analysis: Q4, 2016 By the Numbers : January 26, 2017 Jan 26 2017
Upbeat Q4 Earnings Lift Stryker Jan 25 2017
Stryker (SYK) Beats Q4 Earnings, Provides FY17 Guidance Jan 25 2017
Early movers: BA, UTX, TXT, AAPL, GPS, JBLU & more Jan 25 2017
Edited Transcript of SYK earnings conference call or presentation 24-Jan-17 9:30pm GMT Jan 25 2017
Stryker beats 4Q profit forecasts Jan 24 2017
Stryker beats 4Q profit forecasts Jan 24 2017
Stryker Corp Earnings Call scheduled for 4:30 pm ET today Jan 24 2017
STRYKER CORP Files SEC form 8-K, Results of Operations and Financial Condition Jan 24 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)